Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia gravis...
36 insider purchases on record · latest filing 2024-02-15.
Insiders have also filed 208 sale transactions at XNCR.